A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-08-10

AUTHORS

Elizabeth J. Anderson, Brittany White, Emily Goodwin, Fadi Alkhateeb, Cyle White

ABSTRACT

BackgroundProcalcitonin is a serum biomarker used to distinguish bacterial infection from viral or noninfectious syndromes. Primary literature shows mixed data on use of procalcitonin for de-escalation of antimicrobials. Delays in test results of send-out procalcitonin assays may result in prolonged antimicrobial durations. It is unknown whether availability of rapid-result assays may shorten time to antibiotic de-escalation.AimThis retrospective, cohort study compared antibiotic durations of treatment between groups with rapid-result versus delayed send-out, procalcitonin test modality.This study was exempt from Ethics Committee Approval, as determined by the Institutional Review Board at the study site.MethodAdult hospitalized patients were included if they had at least one procalcitonin test performed during the study period. The primary outcome compared mean duration of antimicrobial therapy between groups receiving a rapid-result procalcitonin test and a send-out test. Secondary outcomes included incidence of Clostridiodes difficile infection, mention of procalcitonin testing in the electronic medical record in reference to antimicrobial therapy decision making, and presence of comorbidities which affect procalcitonin levels independent of infection.ResultsA total of 350 lab results were analyzed. The duration of antimicrobial treatment between groups was not statistically different with the median duration of treatment in the send-out group being 2.95 days compared to 3.35 in the rapid result group, p = 0.856. Patient comorbidities with potential to lead to a noninfectious elevation or falsely high level of procalcitonin were common.ConclusionUse of a rapid-result procalcitonin assay does not reduce hospital antimicrobial therapy duration as compared with send-out testing. More... »

PAGES

1188-1194

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11096-022-01462-z

DOI

http://dx.doi.org/10.1007/s11096-022-01462-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1150126741

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35947325


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Procalcitonin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitals, Community", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Infective Agents", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA", 
          "id": "http://www.grid.ac/institutes/grid.428912.4", 
          "name": [
            "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anderson", 
        "givenName": "Elizabeth J.", 
        "id": "sg:person.07621671754.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07621671754.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA", 
          "id": "http://www.grid.ac/institutes/grid.428912.4", 
          "name": [
            "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "White", 
        "givenName": "Brittany", 
        "id": "sg:person.014236434033.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014236434033.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA", 
          "id": "http://www.grid.ac/institutes/grid.428912.4", 
          "name": [
            "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goodwin", 
        "givenName": "Emily", 
        "id": "sg:person.011214632754.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011214632754.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA", 
          "id": "http://www.grid.ac/institutes/grid.428912.4", 
          "name": [
            "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alkhateeb", 
        "givenName": "Fadi", 
        "id": "sg:person.01301111464.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301111464.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA", 
          "id": "http://www.grid.ac/institutes/grid.428912.4", 
          "name": [
            "Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "White", 
        "givenName": "Cyle", 
        "id": "sg:person.0674425224.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674425224.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11255-013-0542-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023374640", 
          "https://doi.org/10.1007/s11255-013-0542-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2334-11-224", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044592465", 
          "https://doi.org/10.1186/1471-2334-11-224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc13181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028809346", 
          "https://doi.org/10.1186/cc13181"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-08-10", 
    "datePublishedReg": "2022-08-10", 
    "description": "BackgroundProcalcitonin is a serum biomarker used to distinguish bacterial infection from viral or noninfectious syndromes. Primary literature shows mixed data on use of procalcitonin for de-escalation of antimicrobials. Delays in test results of send-out procalcitonin assays may result in prolonged antimicrobial durations. It is unknown whether availability of rapid-result assays may shorten time to antibiotic de-escalation.AimThis retrospective, cohort study compared antibiotic durations of treatment between groups with rapid-result versus delayed send-out, procalcitonin test modality.This study was exempt from Ethics Committee Approval, as determined by the Institutional Review Board at the study site.MethodAdult hospitalized patients were included if they had at least one procalcitonin test performed during the study period. The primary outcome compared mean duration of antimicrobial therapy between groups receiving a rapid-result procalcitonin test and a send-out test. Secondary outcomes included incidence of Clostridiodes difficile infection, mention of procalcitonin testing in the electronic medical record in reference to antimicrobial therapy decision making, and presence of comorbidities which affect procalcitonin levels independent of infection.ResultsA total of 350 lab results were analyzed. The duration of antimicrobial treatment between groups was not statistically different with the median duration of treatment in the send-out group being 2.95\u00a0days compared to 3.35 in the rapid result group, p\u2009=\u20090.856. Patient comorbidities with potential to lead to a noninfectious elevation or falsely high level of procalcitonin were common.ConclusionUse of a rapid-result procalcitonin assay does not reduce hospital antimicrobial therapy duration as compared with send-out testing.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11096-022-01462-z", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044817", 
        "issn": [
          "2210-7703", 
          "2210-7711"
        ], 
        "name": "International Journal of Clinical Pharmacy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "keywords": [
      "procalcitonin test", 
      "procalcitonin testing", 
      "cohort study", 
      "Clostridiodes difficile infection", 
      "antimicrobial therapy duration", 
      "presence of comorbidities", 
      "retrospective cohort study", 
      "use of procalcitonin", 
      "therapy decision making", 
      "send-out test", 
      "ethics committee approval", 
      "electronic medical records", 
      "institutional review board", 
      "noninfectious syndromes", 
      "antibiotic duration", 
      "Secondary outcomes", 
      "procalcitonin levels", 
      "median duration", 
      "patient comorbidities", 
      "primary outcome", 
      "therapy duration", 
      "procalcitonin assays", 
      "ResultsA total", 
      "serum biomarkers", 
      "mean duration", 
      "difficile infection", 
      "antimicrobial duration", 
      "antimicrobial therapy", 
      "medical records", 
      "antibiotic use", 
      "community hospital", 
      "committee approval", 
      "antimicrobial treatment", 
      "bacterial infections", 
      "procalcitonin", 
      "review board", 
      "study period", 
      "infection", 
      "result group", 
      "test modalities", 
      "comorbidities", 
      "treatment", 
      "duration", 
      "lab results", 
      "outcomes", 
      "group", 
      "assays", 
      "BackgroundProcalcitonin", 
      "MethodAdults", 
      "high levels", 
      "patients", 
      "AimThis", 
      "ConclusionUse", 
      "syndrome", 
      "therapy", 
      "hospital", 
      "primary literature", 
      "incidence", 
      "testing", 
      "biomarkers", 
      "study", 
      "modalities", 
      "levels", 
      "total", 
      "test", 
      "antimicrobials", 
      "approval", 
      "elevation", 
      "days", 
      "use", 
      "period", 
      "records", 
      "test results", 
      "decision making", 
      "effect", 
      "presence", 
      "results", 
      "literature", 
      "data", 
      "sites", 
      "delay", 
      "study sites", 
      "time", 
      "potential", 
      "availability", 
      "mention", 
      "reference", 
      "board", 
      "making", 
      "mixed data"
    ], 
    "name": "A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital", 
    "pagination": "1188-1194", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1150126741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11096-022-01462-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35947325"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11096-022-01462-z", 
      "https://app.dimensions.ai/details/publication/pub.1150126741"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_955.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11096-022-01462-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01462-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01462-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01462-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01462-z'


 

This table displays all metadata directly associated to this object as RDF triples.

223 TRIPLES      21 PREDICATES      126 URIs      115 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11096-022-01462-z schema:about N111da469ce884390a9962cf85bc9b2f9
2 N1b2e5953f8ab409b898fdeb7e9172cfc
3 N4819f030b1a448d2831b122b57fe31bc
4 N7dd799281aa44a7eb12a9fa746b5ebe4
5 N80494ee3af1649b68df754b277a82a48
6 Nbafd7919ff3a4ec58e6fa04350523171
7 Neae4d6ea08314103878d75cc5852ad4d
8 Nee57b0ccbc084e3d8d995424c7a8435d
9 anzsrc-for:11
10 anzsrc-for:1103
11 schema:author N15ee5b6a1e08448ba608798bbf3443c1
12 schema:citation sg:pub.10.1007/s11255-013-0542-8
13 sg:pub.10.1186/1471-2334-11-224
14 sg:pub.10.1186/cc13181
15 schema:datePublished 2022-08-10
16 schema:datePublishedReg 2022-08-10
17 schema:description BackgroundProcalcitonin is a serum biomarker used to distinguish bacterial infection from viral or noninfectious syndromes. Primary literature shows mixed data on use of procalcitonin for de-escalation of antimicrobials. Delays in test results of send-out procalcitonin assays may result in prolonged antimicrobial durations. It is unknown whether availability of rapid-result assays may shorten time to antibiotic de-escalation.AimThis retrospective, cohort study compared antibiotic durations of treatment between groups with rapid-result versus delayed send-out, procalcitonin test modality.This study was exempt from Ethics Committee Approval, as determined by the Institutional Review Board at the study site.MethodAdult hospitalized patients were included if they had at least one procalcitonin test performed during the study period. The primary outcome compared mean duration of antimicrobial therapy between groups receiving a rapid-result procalcitonin test and a send-out test. Secondary outcomes included incidence of Clostridiodes difficile infection, mention of procalcitonin testing in the electronic medical record in reference to antimicrobial therapy decision making, and presence of comorbidities which affect procalcitonin levels independent of infection.ResultsA total of 350 lab results were analyzed. The duration of antimicrobial treatment between groups was not statistically different with the median duration of treatment in the send-out group being 2.95 days compared to 3.35 in the rapid result group, p = 0.856. Patient comorbidities with potential to lead to a noninfectious elevation or falsely high level of procalcitonin were common.ConclusionUse of a rapid-result procalcitonin assay does not reduce hospital antimicrobial therapy duration as compared with send-out testing.
18 schema:genre article
19 schema:isAccessibleForFree true
20 schema:isPartOf N63c23dc17d47409b843cd256600de7d4
21 Nf058b3762f8444178c02d121a58eb2bf
22 sg:journal.1044817
23 schema:keywords AimThis
24 BackgroundProcalcitonin
25 Clostridiodes difficile infection
26 ConclusionUse
27 MethodAdults
28 ResultsA total
29 Secondary outcomes
30 antibiotic duration
31 antibiotic use
32 antimicrobial duration
33 antimicrobial therapy
34 antimicrobial therapy duration
35 antimicrobial treatment
36 antimicrobials
37 approval
38 assays
39 availability
40 bacterial infections
41 biomarkers
42 board
43 cohort study
44 committee approval
45 community hospital
46 comorbidities
47 data
48 days
49 decision making
50 delay
51 difficile infection
52 duration
53 effect
54 electronic medical records
55 elevation
56 ethics committee approval
57 group
58 high levels
59 hospital
60 incidence
61 infection
62 institutional review board
63 lab results
64 levels
65 literature
66 making
67 mean duration
68 median duration
69 medical records
70 mention
71 mixed data
72 modalities
73 noninfectious syndromes
74 outcomes
75 patient comorbidities
76 patients
77 period
78 potential
79 presence
80 presence of comorbidities
81 primary literature
82 primary outcome
83 procalcitonin
84 procalcitonin assays
85 procalcitonin levels
86 procalcitonin test
87 procalcitonin testing
88 records
89 reference
90 result group
91 results
92 retrospective cohort study
93 review board
94 send-out test
95 serum biomarkers
96 sites
97 study
98 study period
99 study sites
100 syndrome
101 test
102 test modalities
103 test results
104 testing
105 therapy
106 therapy decision making
107 therapy duration
108 time
109 total
110 treatment
111 use
112 use of procalcitonin
113 schema:name A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital
114 schema:pagination 1188-1194
115 schema:productId N2665bc1a188e486a9fd691ca7047e30e
116 N2a9301d30869463b910c06dd248c06a6
117 Nb95b2b52aa344c9dbadc82b04acca2e6
118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1150126741
119 https://doi.org/10.1007/s11096-022-01462-z
120 schema:sdDatePublished 2022-12-01T06:45
121 schema:sdLicense https://scigraph.springernature.com/explorer/license/
122 schema:sdPublisher N5130081c26404b40ad15642ba740040c
123 schema:url https://doi.org/10.1007/s11096-022-01462-z
124 sgo:license sg:explorer/license/
125 sgo:sdDataset articles
126 rdf:type schema:ScholarlyArticle
127 N0d60bdbc89f14dfcab13f349bac34e89 rdf:first sg:person.01301111464.01
128 rdf:rest Nf63b2abd5b5c487295e341d5963ceea4
129 N111da469ce884390a9962cf85bc9b2f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Biomarkers
131 rdf:type schema:DefinedTerm
132 N15ee5b6a1e08448ba608798bbf3443c1 rdf:first sg:person.07621671754.01
133 rdf:rest N99aee686021f449caa2e56217fdb7fbb
134 N1b2e5953f8ab409b898fdeb7e9172cfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Procalcitonin
136 rdf:type schema:DefinedTerm
137 N1b9424e922df4ecf95ccca704402fcd3 rdf:first sg:person.011214632754.45
138 rdf:rest N0d60bdbc89f14dfcab13f349bac34e89
139 N2665bc1a188e486a9fd691ca7047e30e schema:name dimensions_id
140 schema:value pub.1150126741
141 rdf:type schema:PropertyValue
142 N2a9301d30869463b910c06dd248c06a6 schema:name pubmed_id
143 schema:value 35947325
144 rdf:type schema:PropertyValue
145 N4819f030b1a448d2831b122b57fe31bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Anti-Infective Agents
147 rdf:type schema:DefinedTerm
148 N5130081c26404b40ad15642ba740040c schema:name Springer Nature - SN SciGraph project
149 rdf:type schema:Organization
150 N63c23dc17d47409b843cd256600de7d4 schema:issueNumber 5
151 rdf:type schema:PublicationIssue
152 N7dd799281aa44a7eb12a9fa746b5ebe4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Retrospective Studies
154 rdf:type schema:DefinedTerm
155 N80494ee3af1649b68df754b277a82a48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Anti-Bacterial Agents
157 rdf:type schema:DefinedTerm
158 N99aee686021f449caa2e56217fdb7fbb rdf:first sg:person.014236434033.07
159 rdf:rest N1b9424e922df4ecf95ccca704402fcd3
160 Nb95b2b52aa344c9dbadc82b04acca2e6 schema:name doi
161 schema:value 10.1007/s11096-022-01462-z
162 rdf:type schema:PropertyValue
163 Nbafd7919ff3a4ec58e6fa04350523171 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Hospitals, Community
165 rdf:type schema:DefinedTerm
166 Neae4d6ea08314103878d75cc5852ad4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Cohort Studies
168 rdf:type schema:DefinedTerm
169 Nee57b0ccbc084e3d8d995424c7a8435d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Humans
171 rdf:type schema:DefinedTerm
172 Nf058b3762f8444178c02d121a58eb2bf schema:volumeNumber 44
173 rdf:type schema:PublicationVolume
174 Nf63b2abd5b5c487295e341d5963ceea4 rdf:first sg:person.0674425224.91
175 rdf:rest rdf:nil
176 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
177 schema:name Medical and Health Sciences
178 rdf:type schema:DefinedTerm
179 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
180 schema:name Clinical Sciences
181 rdf:type schema:DefinedTerm
182 sg:journal.1044817 schema:issn 2210-7703
183 2210-7711
184 schema:name International Journal of Clinical Pharmacy
185 schema:publisher Springer Nature
186 rdf:type schema:Periodical
187 sg:person.011214632754.45 schema:affiliation grid-institutes:grid.428912.4
188 schema:familyName Goodwin
189 schema:givenName Emily
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011214632754.45
191 rdf:type schema:Person
192 sg:person.01301111464.01 schema:affiliation grid-institutes:grid.428912.4
193 schema:familyName Alkhateeb
194 schema:givenName Fadi
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301111464.01
196 rdf:type schema:Person
197 sg:person.014236434033.07 schema:affiliation grid-institutes:grid.428912.4
198 schema:familyName White
199 schema:givenName Brittany
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014236434033.07
201 rdf:type schema:Person
202 sg:person.0674425224.91 schema:affiliation grid-institutes:grid.428912.4
203 schema:familyName White
204 schema:givenName Cyle
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674425224.91
206 rdf:type schema:Person
207 sg:person.07621671754.01 schema:affiliation grid-institutes:grid.428912.4
208 schema:familyName Anderson
209 schema:givenName Elizabeth J.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07621671754.01
211 rdf:type schema:Person
212 sg:pub.10.1007/s11255-013-0542-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023374640
213 https://doi.org/10.1007/s11255-013-0542-8
214 rdf:type schema:CreativeWork
215 sg:pub.10.1186/1471-2334-11-224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044592465
216 https://doi.org/10.1186/1471-2334-11-224
217 rdf:type schema:CreativeWork
218 sg:pub.10.1186/cc13181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028809346
219 https://doi.org/10.1186/cc13181
220 rdf:type schema:CreativeWork
221 grid-institutes:grid.428912.4 schema:alternateName Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA
222 schema:name Department of Pharmacy, Erlanger Health System, 975 E 3rd St, 37403, Chattanooga, TN, USA
223 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...